Giuseppe Fasolino

Faculty of Medicine and Pharmacy
UZB Physician, Ophtalmology - Eye surgery

Pleinlaan 2
1050 Brussel
Belgium
Laarbeeklaan 101
1090 Jette
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Giuseppe Fasolino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

169 Citations
5 h-Index
10 Article
1 Poster
1 Meeting abstract (Journal)

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Everaert, H. & Neyns, B., 1 May 2021, In : Cancers (Basel). 13, 9, 13 p., 2010.
Research output: Contribution to journal › Article

Open Access
File
20 Downloads (Pure)
Choriocapillaris Assessment In Patients Under Mek-Inhibitor Therapy For Cutaneous Melanoma: An Optical Coherence Tomography Angiography Study
Fasolino, G., Awada, G., Koulalis, J. S., Neyns, B., Van Elderen, P., Kuijpers, R. W., Nelis, P. & Ten Tusscher, M., 2021, In : Seminars in Ophthalmology. p. 1-7 7 p.
Research output: Contribution to journal › Article
Interim safety and efficacy results of a phase II clinical trial on trametinib and low-dose dabrafenib in patients with advanced BRAFV600 wild-type melanoma
Awada, G., Schwarze, J. K., Reijmen, E., Goyvaerts, C., Fasolino, G., Aspeslagh, S. & Neyns, B., 2020, In : Annals of Oncology. 31, S1, p. S10-S10
Research output: Contribution to journal › Meeting abstract (Journal)

Open Access
File
37 Downloads (Pure)
Interim safety and efficacy results of a phase II clinical trial on trametinib and low-dose dabrafenib in patients with advanced BRAFV600 wild-type melanoma
Awada, G., Schwarze, J. K., Reijmen, E., Goyvaerts, C., Fasolino, G., Aspeslagh, S. & Neyns, B., 2020.
Research output: Unpublished contribution to conference › Poster

File
6 Downloads (Pure)
A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
Pece, A., Milani, P., Monteleone, C., Trombetta, C. J., De Crecchio, G., Fasolino, G., Matranga, D., Cillino, S. & Vadalà, M., Nov 2015, In : Graefe's Archive for Clinical and Experimental Ophthalmology. 253, 11, p. 1867-1872 6 p.
Research output: Contribution to journal › Article
13 Citations (Scopus)

3 Talk or presentation at a conference
1 Participation in conference
1 Participating in or organizing an event at an external academic organisation

ocular toxicity related to new oncological treatment
Giuseppe Fasolino (Speaker)
19 Jun 2021
Activity: Talk or presentation › Talk or presentation at a conference
Manama Meeting UZBrussel
Giuseppe Fasolino (Chair)
19 Jun 2021
Activity: Participating in or organising an event › Participation in conference
brussel retina meeting
Giuseppe Fasolino (Chair)
4 Apr 2019 → 6 Apr 2019
Activity: Participating in or organising an event › Participating in or organizing an event at an external academic organisation
diabetic retinopathy
Giuseppe Fasolino (Speaker)
28 Nov 2019
Activity: Talk or presentation › Talk or presentation at a conference
subtreshold laser treatment in diabetic retinopathy
Giuseppe Fasolino (Speaker)
7 Sep 2019
Activity: Talk or presentation › Talk or presentation at a conference